title: Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?
authors.forename: Aminah
authors.initials: A
authors.lastname: Jatoi
authors.forename: Shauna
authors.initials: S
authors.lastname: Hillman
authors.forename: Philip
authors.initials: P
authors.lastname: Stella
authors.forename: Kendrith
authors.initials: K
authors.lastname: Rowland
authors.forename: Roscoe
authors.initials: R
authors.lastname: Morton
authors.forename: Shaker
authors.initials: S
authors.lastname: Dakhil
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D000077156:Gefitinib; D019538:Health Care Surveys; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008495:Medical Oncology; D018579:Patient Selection; D011287:Prejudice; D011799:Quinazolines / Q000627:therapeutic use; D011795:Surveys and Questionnaires
chemical_list: D011799:Quinazolines; D000077156:Gefitinib